MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy
BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.
It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.
You may also like
Gainers
Latest Crypto News
The SEC Chairman will deliver a speech tonight at the NYSE, outlining the future vision of the U.S. capital markets
U.S. FDIC Acting Chair to Propose Stablecoin Regulation Framework in December
Cryptocurrency Fear and Greed Index Drops to 23, Market Still in "Extreme Fear" State
Grayscale to Launch First Chainlink Spot ETF
Kalshi is partnering with Solana to move its prediction market on-chain.
Customer Support:@weikecs
Business Cooperation:@weikecs
Quant Trading & MM:[email protected]
VIP Services:[email protected]